Variant or unknown test results
In some instances, testing identifies a gene alteration that hasn't been seen in prior families, and there isn't enough information about the alteration to know whether it causes an increased risk of breast or ovarian cancer. This is known as a variant of uncertain significance.
Learning that you have a genetic variant of unknown significance may lead to:
- Confusion and anxiety about your cancer risk
- Frustration over the lack of accurate individualized cancer risk information
- Challenges with making cancer screening, treatment and prevention decisions
Living with test results
Most people would be anxious if given the chance to find out whether their risk of a serious disease was higher than average. In fact, you may decide that you'd rather not know, and just forgo testing altogether. That's a valid choice.
It's also normal to experience sadness, anxiety or even anger if your test results are positive. You might be more likely to experience a more profoundly negative reaction if you didn't expect your results to be positive — for instance, if your family history isn't that significant.
However, research shows that, in the long run, most people cope well with the knowledge of an increased cancer risk and don't experience significant distress over the test results.
The decision to have preventive (prophylactic) surgery if you test positive for the BRCA gene isn't urgent. You have time to research and understand all your options before making a decision. Sometimes it's helpful to seek a second opinion or meet with a breast specialist who can help you weigh the risks and benefits of the available options based on your individual situation.
For many, simply knowing their risk status eases psychological and emotional distress. They can be proactive and establish a personalized plan to deal with their increased risk.
Aug. 25, 2016
- Peshkin BN, et al. Genetic counseling and testing for hereditary breast and ovarian cancer. www.uptodate.com/home. Accessed June 3, 2016.
- Help me understand genetics. Genetics Home Reference. https://ghr.nlm.nih.gov/primer. Accessed June 3, 2016.
- Genetics of breast and gynecologic cancers. National Cancer Institute. http://www.cancer.gov/types/breast/hp/breast-ovarian-genetics-pdq. Accessed June 6, 2016.
- Raby BA, et al. Genetic counseling and testing. http://www.uptodate.com/home. Accessed June 3, 2016.
- Breast cancer risk in American women. National Cancer Institute. http://www.cancer.gov/types/breast/risk-fact-sheet. Accessed July 24, 2016.
- BRCA1 and BRCA2: Cancer risk and genetic testing. National Cancer Institute. http://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet. Accessed June 3, 2016.
- Pruthi S (expert opinion). Mayo Clinic, Rochester, Minn. July 29, 2016.
- AskMayoExpert. Genetic testing for BRCA1 and BRCA2 mutations. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.